COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,430 Articles (22,835 medRxiv, 8,595 bioRxiv)

Most recent first Previous |  Page 1003: Articles 10021-10030  | Next

Testing behaviour may bias observational studies of vaccine effectiveness
Glasziou, P., McCaffery, K. J., Cvejic, E., Batcup, C., Ayre, J., Pickles, K., Bonner, C.
10.1101/2022.01.17.22269450 — Posted: 2022-01-21
An expanded high throughput RT-PCR assay to rapidly identify all known SARS-CoV-2 variants of concern using melting temperature coding.
Banada, P. P., Green, R., Banik, S., Streck, D., Montalvan, I., Reiss, R., Jones, R., Marras, S., Chakravorty, S., Alland, D.
10.1101/2022.01.18.22269424 — Posted: 2022-01-21
Investigating sensitivity of nasal or throat (ISNOT): A combination of both swabs increases sensitivity of SARS-CoV-2 rapid antigen tests
Goodall, B. L., LeBlanc, J. J., Hatchette, T. F., Barrett, L., Patriquin, G.
10.1101/2022.01.18.22269426 — Posted: 2022-01-21
mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients
Teresa Lupo Stanghellini, M., Di Cosimo, S., Costantini, M., Monti, S., Mantegazza, R., Mantovani, A., Salvarani, C., Luigi Zinzani, P., Inglese, M., Ciceri, F., Apolone, G., Ciliberto, G., Baldanti, F., Morrone, A., Sinno, V., Locatelli, F., Notari, S., Turola, E., Giannarelli, D., Silvestris, N.
10.1101/2022.01.18.22269351 — Posted: 2022-01-21
Combination of Spironolactone and Sitagliptin Improves Clinical Outcomes of Outpatients with COVID-19: An Observational Study
Davarpanah, M. A., Adatorwovor, R., Mansoori, Y., Ramsheh, F. S. R., Parsa, A., Hajiani, M., Faramarzi, H., Kavuluru, R., Asadipooya, K.
10.1101/2022.01.21.22269322 — Posted: 2022-01-21
ReadItAndKeep: rapid decontamination of SARS-CoV-2 sequencing reads
Hunt, M., Swann, J., Constantinides, B., Fowler, P. W., Iqbal, Z.
10.1101/2022.01.21.477194 — Posted: 2022-01-21
Nanoformulated Remdesivir with Extremely Low Content of Poly(2-oxazoline) - Based Stabilizer for Aerosol Treatment of COVID-19
Ramsey, J. D., Stewart, I. E., Madden, E. A., Lim, C., Hwang, D., Heise, M. T., Hickey, A. J., Kabanov, A. V.
10.1101/2022.01.21.477258 — Posted: 2022-01-21
Outbreak.info: A standardized, searchable platform to discover and explore COVID-19 resources and data
Tsueng, G., Mullen, J., Alkuzweny, M., Cano, M. A., Rush, B., Haag, E., Outbreak Curators, , Latif, A. A., Zhou, X., Qian, Z., Andersen, K. G., Wu, C., Su, A. I., Gangavarapu, K., Hughes, L. D.
10.1101/2022.01.20.477133 — Posted: 2022-01-21
Sialic acid and fucose residues on the SARS-CoV-2 receptor binding domain modulate IgG reactivity
Samuelsson, E., Mirgorodskaya, E., Nyström, K., Bäckström, M., Liljeqvist, J.-A., Norden, R.
10.1101/2022.01.20.477056 — Posted: 2022-01-21
Microbial GWAS studies revealing combinations of Omicron RBD mutations existed and may contribute to antibody evasion and ACE2 binding
Ou, X., Yang, Z., Zhu, D., Mao, S., Wang, M., Jia, R., Chen, S., Liu, M., Yang, Q., Wu, Y., Zhao, X., Zhang, S., Huang, J., Gao, Q., Liu, Y., Zhang, L., Peppelenbosch, M., Pan, Q., Cheng, A.-c.
10.1101/2022.01.19.22269510 — Posted: 2022-01-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).